Anúncio
Anúncio
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
78.18
USDPatrocinado
-0.81
-1.03%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
77.39
-0.79
-1.01%
Relatórios de Lucros MIRM
Rácio de surpresa positiva
MIRM separação 13 de 26 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$138.44M
/-$0.06
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+4.08%
/-220.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+39.25%
/-87.76%
Mirum Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, MIRM reported earnings of 0.05 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 129.76% surprise. Revenue reached 133.01 milhão, compared to an expected 132.68 milhão, with a 0.25% difference. The market reacted with a -1.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -0.06 USD, with revenue projected to reach 138.44 milhão USD, implying an diminuir of -220.00% EPS, and aumentar of 4.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Mirum Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Mirum Pharmaceuticals, Inc. Common Stock reported EPS of $0.05, beating estimates by 129.76%, and revenue of $133.01M, 0.25% above expectations.
How did the market react to Mirum Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.24%, changed from $70.97 before the earnings release to $70.09 the day after.
When is Mirum Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Mirum Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 12
analistas, Mirum Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.06 and revenue of $138.44M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio